Sustainability Report in the context of pandemic from legitimacy theory and stakeholder theory perspective - A case study of Nordic Region Pharmaceutical companies
(2022) BUSN79 20221Department of Business Administration
- Abstract
- Purpose:
This study aims to determine how a company uses
sustainability reporting to engage its stakeholders, with a view
toward analysing legitimacy theory and stakeholder theory.
Sustainability disclosure is a key source for determining
whether a stakeholder will keep a relationship with a
company. Focusing on pharmaceuticals in the Nordic region
yields more conclusive results because the Nordic countries
place a high priority on sustainability.
Methodology: Qualitative approach using Content Analysis method
Theoretical perspective:
This study is based on the sustainability reporting theory and
previous research results on its impact on the sustainability
practices of pharmaceutical companies.
Empirical Foundation:
... (More) - Purpose:
This study aims to determine how a company uses
sustainability reporting to engage its stakeholders, with a view
toward analysing legitimacy theory and stakeholder theory.
Sustainability disclosure is a key source for determining
whether a stakeholder will keep a relationship with a
company. Focusing on pharmaceuticals in the Nordic region
yields more conclusive results because the Nordic countries
place a high priority on sustainability.
Methodology: Qualitative approach using Content Analysis method
Theoretical perspective:
This study is based on the sustainability reporting theory and
previous research results on its impact on the sustainability
practices of pharmaceutical companies.
Empirical Foundation:
The qualitative study is based on a sample of the top ten
Nordic pharmaceutical companies for the years 2019 - 2021.
Conclusion:
Through content analysis, this study discusses the legitimacy
and stakeholder theory perspective of Nordic pharmaceutical
companies' disclosure of Sustainability Reports in the context
of a pandemic. The analysis shows that most pharmaceutical
companies improved the overall sustainable disclosure level
during the pandemic, especially in the aspect of social
sustainability, and paid more attention to drug access,
employee health and safety, and human rights, but lacked in
the aspect of environmental sustainability. The research shows
that Nordic pharmaceutical companies create reports
according to EU directives and regional rules such as GRI and
SASB standards, and the preparation of enterprise
sustainability reports during the pandemic is consistent with
the legitimacy theory and stakeholder theory. The study
emphasised the possible impact of pandemic on sustainable
reporting of pharmaceutical companies, and revealed the
internal relationship between sustainable reporting and related
theories. (Less)
Please use this url to cite or link to this publication:
http://lup.lub.lu.se/student-papers/record/9095866
- author
- Idowu-Aire, Oloruntobiloba LU and Li, Nanxi
- supervisor
- organization
- course
- BUSN79 20221
- year
- 2022
- type
- H1 - Master's Degree (One Year)
- subject
- keywords
- Sustainability Reporting, pharmaceutical industry, nonfinancial information disclosure, stakeholder theory, legitimacy theory
- language
- English
- id
- 9095866
- date added to LUP
- 2022-09-19 14:39:27
- date last changed
- 2022-09-19 14:39:27
@misc{9095866,
abstract = {{Purpose:
This study aims to determine how a company uses
sustainability reporting to engage its stakeholders, with a view
toward analysing legitimacy theory and stakeholder theory.
Sustainability disclosure is a key source for determining
whether a stakeholder will keep a relationship with a
company. Focusing on pharmaceuticals in the Nordic region
yields more conclusive results because the Nordic countries
place a high priority on sustainability.
Methodology: Qualitative approach using Content Analysis method
Theoretical perspective:
This study is based on the sustainability reporting theory and
previous research results on its impact on the sustainability
practices of pharmaceutical companies.
Empirical Foundation:
The qualitative study is based on a sample of the top ten
Nordic pharmaceutical companies for the years 2019 - 2021.
Conclusion:
Through content analysis, this study discusses the legitimacy
and stakeholder theory perspective of Nordic pharmaceutical
companies' disclosure of Sustainability Reports in the context
of a pandemic. The analysis shows that most pharmaceutical
companies improved the overall sustainable disclosure level
during the pandemic, especially in the aspect of social
sustainability, and paid more attention to drug access,
employee health and safety, and human rights, but lacked in
the aspect of environmental sustainability. The research shows
that Nordic pharmaceutical companies create reports
according to EU directives and regional rules such as GRI and
SASB standards, and the preparation of enterprise
sustainability reports during the pandemic is consistent with
the legitimacy theory and stakeholder theory. The study
emphasised the possible impact of pandemic on sustainable
reporting of pharmaceutical companies, and revealed the
internal relationship between sustainable reporting and related
theories.}},
author = {{Idowu-Aire, Oloruntobiloba and Li, Nanxi}},
language = {{eng}},
note = {{Student Paper}},
title = {{Sustainability Report in the context of pandemic from legitimacy theory and stakeholder theory perspective - A case study of Nordic Region Pharmaceutical companies}},
year = {{2022}},
}